These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 37699851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
    Bülow NS, Skouby SO, Warzecha AK, Udengaard H, Andersen CY, Holt MD, Grøndahl ML, Nyboe Andersen A, Sopa N, Mikkelsen ALE, Pinborg A, Macklon NS.
    Hum Reprod; 2022 Jan 28; 37(2):309-321. PubMed ID: 34792133
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial.
    Cédrin-Durnerin I, Carton I, Massin N, Chevalier N, Dubourdieu S, Bstandig B, Michelson X, Goro S, Jung C, Guivarc'h-Lévêque A.
    Hum Reprod; 2024 Sep 01; 39(9):1979-1986. PubMed ID: 39008826
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Sep 05; 38(9):1807-1815. PubMed ID: 37354554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME, Dahhan T, Beerendonk CCM, Fleischer K, Stoop D, Bos AME, Lambalk CB, Schats R, Smeenk JMJ, Louwé LA, Cantineau AEP, de Bruin JP, Linn SC, van der Veen F, van Wely M, Goddijn M.
    Hum Reprod; 2022 Jul 30; 37(8):1786-1794. PubMed ID: 35776109
    [Abstract] [Full Text] [Related]

  • 10. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Pors SE, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Apr 03; 38(4):716-725. PubMed ID: 36721920
    [Abstract] [Full Text] [Related]

  • 11. Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol.
    Poulsen LC, Warzecha AK, Bülow NS, Bungum L, Macklon NS, Yding Andersen C, Skouby SO.
    Hum Reprod; 2022 Jun 30; 37(7):1557-1571. PubMed ID: 35652260
    [Abstract] [Full Text] [Related]

  • 12. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
    Bosch E, Alamá P, Romero JL, Marí M, Labarta E, Pellicer A.
    Hum Reprod; 2024 Feb 01; 39(2):393-402. PubMed ID: 38037188
    [Abstract] [Full Text] [Related]

  • 13. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM, Martínez F, Rodríguez I, Polyzos NP.
    Hum Reprod; 2024 May 02; 39(5):1098-1104. PubMed ID: 38498835
    [Abstract] [Full Text] [Related]

  • 14. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
    Lobo R, Soerdal T, Ekerhovd E, Cohlen B, Porcu E, Schenk M, Shufaro Y, Smeenk J, Suerdieck MB, Pinton P, Pinborg A, BEYOND Investigators .
    Hum Reprod; 2024 May 09. PubMed ID: 38723189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles.
    Thomsen LH, Kesmodel US, Erb K, Bungum L, Pedersen D, Hauge B, Elbæk HO, Povlsen BB, Andersen CY, Humaidan P.
    Hum Reprod; 2018 Aug 01; 33(8):1506-1516. PubMed ID: 29955789
    [Abstract] [Full Text] [Related]

  • 18. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
    Colombo C, Pistoljevic-Kristiansen N, Saupstad M, Bergenheim SJ, Spangmose AL, Klajnbard A, la Cour Freiesleben N, Løkkegaard EC, Englund AL, Husth M, Breth Knudsen U, Alsbjerg B, Prætorius L, Løssl K, Schmidt L, Pinborg A.
    Hum Reprod; 2023 Oct 03; 38(10):1970-1980. PubMed ID: 37634089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.